The 10-12 MeV segment of the medical cyclotron market is expected to witness steady growth in the coming years. These cyclotrons are widely used for the production of isotopes for medical imaging and diagnosis. The increasing prevalence of cancer and other chronic diseases is driving the demand for advanced imaging technologies, thereby boosting the growth of this segment.
16-18 MeV:
The 16-18 MeV segment of the medical cyclotron market is anticipated to experience significant growth, owing to the rising adoption of positron emission tomography (PET) scans for early disease detection. Cyclotrons in this range are capable of producing a wide range of isotopes, making them suitable for various diagnostic applications in healthcare facilities.
19-24 MeV:
The 19-24 MeV segment of the medical cyclotron market is poised for substantial growth, as these cyclotrons are ideal for the production of high-energy isotopes used in cancer treatment and research. The increasing focus on personalized medicine and targeted therapies is driving the demand for cyclotrons in this energy range.
24 MeV & Above:
The 24 MeV and above segment of the medical cyclotron market is expected to witness robust growth due to the growing demand for cyclotrons with higher energy levels for the production of radioisotopes used in nuclear medicine. These cyclotrons are capable of producing a wide range of isotopes for both diagnostic imaging and therapeutic applications, making them essential in modern healthcare settings.